Dr. Gary M. Kirsh

Dr. Gary M. Kirsh was named Chief Executive Officer of Cardiovascular Logistics effective immediately in July 2026, taking leadership of one of the nation's leading cardiology management services organizations. Dr. Kirsh is a nationally recognized urologist, physician-executive and healthcare entrepreneur with more than 30 years of experience advancing physician-led care models.

Dr. Kirsh earned his medical degree from the University of Chicago and completed his residency at Case Western in Cleveland, Ohio, finishing his medical training in 1989. Before his medical career, Gary obtained a Bachelor's degree in Biology from Indiana University Bloomington. He started practicing in Cincinnati because he had spent much of his childhood there, and previously worked as a physician at Urology Associates of Southern Ohio, Inc.

Career History

• Chief Executive Officer, Cardiovascular Logistics (2026–present)
• Board Chairman, Cardiovascular Logistics (January 2026–July 2026)
• Co-founder and Chief Executive Officer, Solaris Health (2020–2025); led the organization from two practices to 1,000 providers across 250+ practice locations in 14 states, becoming the largest urology management services organization in the United States; sold to Cardinal Health for approximately $2.4 billion in November 2025
• President, The Urology Group in Cincinnati (2009–2020)

As one of the founding members of the Large Urology Group Practice Association (LUGPA) and long-term president of The Urology Group in Cincinnati, Ohio, Dr. Kirsh is keenly aware of and uniquely situated to advocate for physician issues at the community, state, and US federal levels. He has testified in Congress on health policy matters and formed meaningful relationships with policymakers from both sides of the aisle through LUGPA over the past 16 years.

What Dr. Kirsh could bring to Chief Executive Officer at Cardiovascular Logistics: Based on his track record, Dr. Kirsh brings proven expertise in scaling physician-led specialty platforms and building national management organizations from early-stage to market-leading positions. His experience successfully navigating the sale of Solaris Health to a Fortune 15 company demonstrates capability in complex M&A transactions and enterprise integration. His deep involvement in healthcare policy advocacy and congressional testimony positions him to navigate regulatory environments effectively. His commitment to preserving physician leadership and clinical autonomy while achieving national scale directly aligns with CVL's stated mission to combine premier cardiology practices without compromising their exceptional characteristics.